Direct chiral separation of troglitazone stereoisomers using reversed-phase high-performance liquid chromatography

被引:5
作者
Suzuki, N
Takemura, A
Miyamoto, A
Yoshioka, T
Tsutsumi, S
Kawasaki, T
机构
[1] Sankyo Co Ltd, Prod Dev Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[3] Sankyo Co Ltd, Biomed Res Lab, Shinagawa Ku, Tokyo 1408710, Japan
关键词
troglitazone; anti-diabetic drug; chiral separation; reversed-phase LC; chiral column;
D O I
10.1016/S0731-7085(02)00391-6
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple HPLC method for the direct chiral separation of troglitazone stercoisomers was developed. The separation was performed on a reversed-phase cellulose-derivertized chiral column (Chiralcel OJ-R) using a mobile phase consisting of methanol-acetic acid (1000:1, v/v) at a flow rate of 0.5 ml/min. The peak areas of stereoisomers separated from 0.13 to 0.75 mg/ml of troglitazone had good linearity, with correlation coefficients > 0.999 in the reversed-phase mode. The repeatability of the ratios of stereoisomers isolated from 0.5 mg/ml of troglitazone had a relative standard deviation of 0.1-0.2%. The relative sensitivities of the four isomers at UV 285 nm were similar, as each response factor was within the range of 0.99-1.01. Troglitazone racemized at the chiral center of the thiazolidine ring in methanol solution, but was found to be stable for 24 h in methanol-acetic acid (1000:1, v/v). This method was applied to the stercoisomeric analysis of troglitazone in pharmaceutical formulations and used to evaluate the constancy of the stereoisomer ratio in the manufacturing process and stability testing. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:823 / 836
页数:14
相关论文
共 19 条
[1]   STRUCTURAL FACTORS AFFECTING CHIRAL RECOGNITION AND SEPARATION ON CELLULOSE BASED CHIRAL STATIONARY PHASES [J].
ABOULENEIN, HY ;
ISLAM, MR .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1990, 13 (03) :485-492
[2]   BIAS IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ ;
WUIS, EW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (04) :361-363
[3]   STEREOCHEMISTRY - A SOURCE OF PROBLEMS IN MEDICINAL CHEMISTRY [J].
ARIENS, EJ .
MEDICINAL RESEARCH REVIEWS, 1986, 6 (04) :451-466
[4]   STEREOCHEMISTRY, A BASIS FOR SOPHISTICATED NONSENSE IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :663-668
[5]   NOVEL TOTAL SYNTHESIS OF (2R,4'R,8'R)-ALPHA-TOCOPHEROL (VITAMIN-E) - CONSTRUCTION OF CHIRAL CHROMANS FROM AN OPTICALLY-ACTIVE, NON-AROMATIC PRECURSOR [J].
COHEN, N ;
LOPRESTI, RJ ;
SAUCY, G .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1979, 101 (22) :6710-6716
[6]  
*DAIC CHEM IND LTD, APPL GUID CHIR COL S, P38
[7]   CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].
FUJIWARA, T ;
YOSHIOKA, S ;
YOSHIOKA, T ;
USHIYAMA, I ;
HORIKOSHI, H .
DIABETES, 1988, 37 (11) :1549-1558
[8]  
HORIKOSHI H, 1994, ANN REP SANKYO RES L, V46, P1
[9]   High-performance liquid chromatographic determination of the insulin sensitizing agent DRF-2189 in rat plasma [J].
Jajoo, HK ;
Mamidi, NVSR ;
Kasiram, K ;
Prakash, AS ;
Kumar, VVSS ;
Rao, PB ;
Bhushan, V ;
Subramaniam, S .
JOURNAL OF CHROMATOGRAPHY B, 1998, 707 (1-2) :241-246
[10]   Crystal and molecular structure of (±)-(5R*)-[4-(6-hydroxy-(2R*)-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]2,4-dioxothiazolidine monohydrate [J].
Kobayashi, K ;
Fukuhara, H ;
Hata, T .
ANALYTICAL SCIENCES, 2000, 16 (04) :443-444